A Piece Of The Puzzle Missing From Clover Health Investments, Corp.’s (NASDAQ:CLOV) 26% Share Price Climb
Clover Health Investments, Corp. (NASDAQ:CLOV) shareholders are no doubt pleased to see that the share price has bounced 26% in the last month, although it is still struggling to make up recently lost ground. Notwithstanding the latest gain, the annual share price return of 9.6% isn’t as impressive.
Although its price has surged higher, there still wouldn’t be many who think Clover Health Investments’ price-to-sales (or “P/S”) ratio of 0.9x is worth a mention when the median P/S in the United States’ Healthcare industry is similar at about 1.3x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.
